Do buprenorphine doses and ratios matter in medication assisted treatment adherence?
Introduction: Buprenorphine (BUP), generally prescribed as buprenorphine/naloxone, is a key component of medication-assisted treatment (MAT) to manage opioid use disorder. Studies suggest higher doses of BUP increase treatment adherence. Routine urine drug screens (UDS) assist in monitoring MAT adhe...
Saved in:
Main Authors: | Kevin Kavanagh, PharmD, BCPP (Author), Kimberly Tallian, PharmD, APh, BCPP (Author), Joe A. Sepulveda, MD, FAPA, FASAM (Author), Sarah Rojas, MD (Author), Shedrick Martin, PharmD, BCPP (Author), Harminder Sikand, PharmD (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021) -
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021) -
Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021) -
Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024) -
Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023)